A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

Having multiple sclerosis taught columnist Ahna Crum how to disappear, but she's finding reasons now to let herself be seen and known.

Children with MS who have more paramagnetic rim lesions, or chronic inflammation, tend to show faster declines in brain ...

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

Multiple Sclerosis Awareness Month highlights education, advocacy, research support, and ways to uplift the MS community throughout March.

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Columnist Ben Hofmeister remembers an Army jump and a parachute that didn't open as he reflects on how he became aware of his MS symptoms.

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Learn 10 key facts about multiple sclerosis, including symptoms, treatments, diagnosis, and ways to manage the condition and live well.